Results for the quarter and financial year ended March 31, 2026
PIIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.8 pts less than Nifty Midcap 150 and 7.0 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
PI Industries reported a significant revenue decline for FY2026, with revenue from operations falling to ₹61,827 million from ₹75,712 million in the previous year (approx 18% decline). Profit after tax declined to ₹14,348 million from ₹18,665 million (approx 23% decline), with EPS dropping to ₹94.57 from ₹123.03. The quarter ended March 2026 saw revenue of ₹13,914 million and PAT of ₹1,978 million. An exceptional item loss of ₹1,117 million was recognized due to provision for impairment of investment in subsidiary PI Health Sciences Ltd. Total dividend of ₹15 per share was recommended (₹5 interim already paid + ₹10 final). The company also announced leadership changes including resignation of Joint Managing Director Rajnish Sarna and appointment of Dr. Atul Kumar Gupta as Whole-time Director. Auditors issued an unmodified (clean) opinion.
The substantial decline in revenue and profit marks a challenging year for PI Industries, driven partly by exceptional impairment charges. While the clean audit and maintained dividend provide some comfort, shareholders may remain cautious given the ~18% revenue drop and ~23% PAT decline year-over-year.